Cabot Corporation Forecasted to Earn Q1 2018 Earnings of $0.75 Per Share (CBT)
Cabot Corporation (NYSE:CBT) – Research analysts at KeyCorp issued their Q1 2018 EPS estimates for shares of Cabot Corporation in a research report issued on Thursday. KeyCorp analyst M. Sison expects that the specialty chemicals company will post earnings per share of $0.75 for the quarter. KeyCorp has a “Hold” rating on the stock. KeyCorp also issued estimates for Cabot Corporation’s Q2 2018 earnings at $0.95 EPS, Q3 2018 earnings at $0.98 EPS and Q4 2018 earnings at $1.02 EPS.
Cabot Corporation (NYSE:CBT) last issued its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.93 by ($0.02). Cabot Corporation had a return on equity of 15.11% and a net margin of 8.87%. The business had revenue of $723.00 million for the quarter, compared to analyst estimates of $683.30 million. During the same quarter in the previous year, the business posted $1.00 earnings per share. The business’s revenue was up 16.8% on a year-over-year basis.
ILLEGAL ACTIVITY WARNING: “Cabot Corporation Forecasted to Earn Q1 2018 Earnings of $0.75 Per Share (CBT)” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/cabot-corporation-forecasted-to-earn-q1-2018-earnings-of-0-75-per-share-cbt/1682571.html.
CBT has been the subject of a number of other reports. Loop Capital started coverage on Cabot Corporation in a report on Thursday, September 28th. They set a “hold” rating and a $59.00 price target for the company. Zacks Investment Research downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. ValuEngine downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a report on Friday, July 28th. J P Morgan Chase & Co upgraded Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price target for the company in a report on Tuesday, August 15th. Finally, BidaskClub downgraded Cabot Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Cabot Corporation presently has an average rating of “Hold” and an average target price of $61.14.
Shares of Cabot Corporation (NYSE:CBT) traded up $0.65 during trading on Monday, reaching $64.64. The company’s stock had a trading volume of 26,089 shares, compared to its average volume of 328,906. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.17 and a current ratio of 1.70. Cabot Corporation has a 52-week low of $47.99 and a 52-week high of $64.21. The firm has a market cap of $3,959.98, a P/E ratio of 18.66, a P/E/G ratio of 1.68 and a beta of 1.11.
Several institutional investors and hedge funds have recently modified their holdings of CBT. AJO LP grew its stake in shares of Cabot Corporation by 196.4% in the 2nd quarter. AJO LP now owns 918,731 shares of the specialty chemicals company’s stock valued at $49,088,000 after buying an additional 608,799 shares during the period. Deprince Race & Zollo Inc. acquired a new stake in shares of Cabot Corporation in the 2nd quarter valued at about $27,643,000. BlackRock Inc. grew its stake in shares of Cabot Corporation by 7.2% in the 2nd quarter. BlackRock Inc. now owns 7,544,005 shares of the specialty chemicals company’s stock valued at $403,077,000 after buying an additional 505,594 shares during the period. Earnest Partners LLC grew its stake in shares of Cabot Corporation by 41.8% in the 2nd quarter. Earnest Partners LLC now owns 1,491,521 shares of the specialty chemicals company’s stock valued at $79,692,000 after buying an additional 439,350 shares during the period. Finally, BNP Paribas Arbitrage SA grew its stake in shares of Cabot Corporation by 433.2% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 440,191 shares of the specialty chemicals company’s stock valued at $24,563,000 after buying an additional 357,639 shares during the period. Institutional investors own 84.66% of the company’s stock.
In other news, insider Hobart Kalkstein sold 3,881 shares of the firm’s stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $53.39, for a total value of $207,206.59. Following the completion of the sale, the insider now directly owns 27,736 shares in the company, valued at approximately $1,480,825.04. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 2.50% of the company’s stock.
Cabot Corporation Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.